Plato Investment Management Ltd Grows Holdings in CME Group Inc. (NASDAQ:CME)

Plato Investment Management Ltd boosted its holdings in CME Group Inc. (NASDAQ:CMEFree Report) by 3.1% in the 4th quarter, Holdings Channel reports. The firm owned 15,860 shares of the financial services provider’s stock after purchasing an additional 470 shares during the period. Plato Investment Management Ltd’s holdings in CME Group were worth $3,697,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Meyer Handelman Co. purchased a new stake in CME Group in the 4th quarter valued at $6,144,000. Spire Wealth Management increased its stake in CME Group by 37.4% in the 4th quarter. Spire Wealth Management now owns 1,320 shares of the financial services provider’s stock valued at $307,000 after buying an additional 359 shares during the period. AEGON ASSET MANAGEMENT UK Plc increased its stake in CME Group by 19.3% in the 4th quarter. AEGON ASSET MANAGEMENT UK Plc now owns 326,098 shares of the financial services provider’s stock valued at $75,730,000 after buying an additional 52,862 shares during the period. Bank of Montreal Can increased its stake in CME Group by 41.8% in the 3rd quarter. Bank of Montreal Can now owns 1,028,090 shares of the financial services provider’s stock valued at $224,432,000 after buying an additional 303,169 shares during the period. Finally, Geode Capital Management LLC increased its stake in CME Group by 1.8% in the 3rd quarter. Geode Capital Management LLC now owns 8,284,745 shares of the financial services provider’s stock valued at $1,823,964,000 after buying an additional 142,692 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Price Performance

CME Group stock opened at $253.77 on Monday. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $254.40. The company has a quick ratio of 1.02, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. The firm’s 50-day simple moving average is $238.42 and its 200 day simple moving average is $229.22. The firm has a market capitalization of $91.45 billion, a PE ratio of 26.24, a P/E/G ratio of 6.76 and a beta of 0.57.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings data on Wednesday, February 12th. The financial services provider reported $2.52 EPS for the quarter, topping the consensus estimate of $2.46 by $0.06. CME Group had a net margin of 57.52% and a return on equity of 13.62%. On average, equities research analysts predict that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group announced that its board has initiated a share buyback program on Thursday, December 5th that allows the company to buyback $3.00 billion in shares. This buyback authorization allows the financial services provider to buy up to 3.4% of its shares through open market purchases. Shares buyback programs are often an indication that the company’s board believes its shares are undervalued.

CME Group Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, March 26th. Investors of record on Friday, March 7th will be given a $1.25 dividend. The ex-dividend date is Friday, March 7th. This is a positive change from CME Group’s previous quarterly dividend of $1.15. This represents a $5.00 annualized dividend and a dividend yield of 1.97%. CME Group’s payout ratio is currently 51.71%.

Insider Buying and Selling at CME Group

In other news, insider Julie Winkler sold 11,592 shares of the stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $249.17, for a total transaction of $2,888,378.64. Following the transaction, the insider now directly owns 21,885 shares in the company, valued at $5,453,085.45. This represents a 34.63 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, insider Hilda Harris Piell sold 3,984 shares of the stock in a transaction dated Thursday, February 27th. The stock was sold at an average price of $250.47, for a total transaction of $997,872.48. Following the transaction, the insider now owns 27,046 shares in the company, valued at approximately $6,774,211.62. The trade was a 12.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 0.30% of the stock is owned by insiders.

Analysts Set New Price Targets

Several equities analysts have issued reports on the stock. Barclays boosted their price objective on shares of CME Group from $257.00 to $263.00 and gave the company an “equal weight” rating in a research note on Thursday, February 13th. Citigroup cut shares of CME Group from a “buy” rating to a “neutral” rating and dropped their price objective for the company from $255.00 to $250.00 in a research note on Monday, January 6th. Piper Sandler boosted their price objective on shares of CME Group from $250.00 to $258.00 and gave the company an “overweight” rating in a research note on Tuesday, January 7th. Morgan Stanley boosted their price objective on shares of CME Group from $256.00 to $263.00 and gave the company an “equal weight” rating in a research note on Wednesday, February 19th. Finally, Oppenheimer upped their price target on shares of CME Group from $258.00 to $269.00 and gave the stock an “outperform” rating in a research note on Thursday, February 13th. Four research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $236.13.

View Our Latest Report on CME

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.